Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect
PubMed laboratory research record [PMID: 25876019] PubMed record related to this compound for laboratory literature review
6 Glycolysis and Fatty Acid metabolism gene expression signatures and survival outcomes in adjuvant 5FU-based chemotherapy
Our collection of meals designed to complement GLP-1 medications makes healthy eating approachable, satisfying, and even exciting.
US$ 24.98
US$ 24.57
US$ 22.09
US$ 25.84
